184 related articles for article (PubMed ID: 36711366)
1. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
[TBL] [Abstract][Full Text] [Related]
3. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
5. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
7. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
[TBL] [Abstract][Full Text] [Related]
8. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.
Göncü T; Özdek S; Ünlü M
Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
Yang CS; Hung KC; Huang YM; Hsu WM
J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
11. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eur J Ophthalmol; 2009; 19(4):618-21. PubMed ID: 19551678
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Modarres M; Nazari H; Falavarjani KG; Naseripour M; Hashemi M; Parvaresh MM
Eur J Ophthalmol; 2009; 19(5):848-52. PubMed ID: 19787608
[TBL] [Abstract][Full Text] [Related]
13. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
17. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
Gupta A; Bansal R; Gupta V; Dogra MR
Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
[TBL] [Abstract][Full Text] [Related]
18. Ziv-aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial.
Aleman I; Castillo Velazquez J; Rush SW; Rush RB
Br J Ophthalmol; 2019 Dec; 103(12):1740-1746. PubMed ID: 30705040
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
20. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Antoszyk AN; Glassman AR; Beaulieu WT; Jampol LM; Jhaveri CD; Punjabi OS; Salehi-Had H; Wells JA; Maguire MG; Stockdale CR; Martin DF; Sun JK;
JAMA; 2020 Dec; 324(23):2383-2395. PubMed ID: 33320223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]